智能生物解决方案公司通过与西班牙和安道尔的战略合作，强调了持续的扩展-动脉网

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

GlobeNewswire 等信源发布 2025-03-27 09:00



可切换为仅中文







INBS set to capitalize on growing Spanish Drug Testing Market,

INBS准备利用不断增长的西班牙药物测试市场，

anticipated to reach $448 million by 2030

预计到2030年将达到4.48亿美元

Major Spanish accounts currently require 1,000 drug testing cartridges per month

西班牙主要账户目前每月需要1000个药物测试盒。

NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ('INBS' or the 'Company'), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has expanded access to its fingerprint drug testing in Spain and Andorra through a strategic collaboration with Detecto, a division of Spanish distributor MTB Distribuciones Tecnologicas SL ('MTB')..

纽约，2025年3月27日（环球新闻社）-- Intelligent Bio Solutions Inc.（纳斯达克股票代码：INBS）（“INBS”或“公司”），一家提供智能、快速、无创检测解决方案的医疗技术公司，今日宣布通过与Detecto（西班牙分销商MTB Distribuciones Tecnologicas SL（“MTB”）旗下部门）的战略合作，已将其指纹药物检测推广至西班牙和安道尔。

MTB established Detecto following decades of experience in clinical distribution, recognizing the market's evolving needs and increasing demand for drug testing across various sectors. Detecto is now a leading provider of drug testing solutions throughout Spain and Andorra. INBS' partnership with Detecto aims to leverage the strengths of both companies and expand access to fingerprint sweat-based drug testing across various sectors, including workplace safety and transportation..

MTB凭借其在临床分销领域数十年的经验，认识到市场不断变化的需求以及各行业对药物检测需求的增加，因此创立了Detecto。如今，Detecto已成为西班牙和安道尔地区药物检测解决方案的领先供应商。INBS与Detecto的合作旨在发挥两家公司的优势，扩大基于指纹汗液的药物检测在多个领域的应用，包括工作场所安全和交通运输。

Detecto already supplies INBS' solution to major clients in these sectors, including transportation network, Metro Barcelona, and one of Spain's largest mines based out of Rio Tinto, where INBS’ solution is integrated into existing security protocols to enhance workplace safety. The testing volumes of these accounts currently require a supply of 1,000 cartridges per month to Detecto, reflecting the trust and confidence these accounts place in INBS' technology.

Detecto 已经向这些领域的主要客户供应了 INBS 的解决方案，其中包括交通网络、巴塞罗那地铁，以及西班牙最大的里奥廷托矿山之一。在这些地方，INBS 的解决方案被整合到现有的安全协议中，以提高工作场所的安全性。这些客户的测试量目前要求 Detecto 每月提供 1,000 个墨盒，这反映了这些客户对 INBS 技术的信任和信心。

The Company’s drug testing system has been well received among Detecto's clients due to its non-invasive nature, ease of collection, and increased acceptance among workers. Additionally, the system's yearly calibration reduces maintenance costs compared to other devices..

由于该公司的药物测试系统具有非侵入性、易于收集样本以及受到工人普遍接受的特点，因此在Detecto的客户中广受欢迎。此外，该系统每年一次的校准也降低了维护成本，相较其他设备更具优势。

'Detecto's success in securing these large accounts in Spain is a strong indication of the wider adoption of our technology in the country,' said Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions. 'These strategic partnerships are key to our expansion into the European market and the broader implementation of fingerprint drug screening across additional regions.' .

“Detecto在西班牙成功确保这些大客户，这充分表明我们的技术在该国得到了更广泛的应用，”Intelligent Bio Solutions全球销售副总裁Doug Heath表示。“这些战略合作伙伴关系对我们进军欧洲市场以及在更多地区广泛实施指纹药物筛查至关重要。”

The Spanish drug testing market is anticipated to reach $448 million by 2030

西班牙药物检测市场预计到2030年将达到4.48亿美元。

, driven by efforts to prevent drug abuse, a growing acceptance of drug screening as a critical tool for maintaining safety, and rising illicit drug use. Detecto is broadening its focus to include law enforcement and rehabilitation while proactively engaging with the maritime sector. Additionally, Detecto sees strong growth potential in ports, mining and transportation..

，为了防止药物滥用，人们越来越接受将药物筛查作为维护安全的关键工具，同时毒品使用也在增加。Detecto正在拓宽其关注点，将其包括执法和康复领域，同时积极与海事部门接触。此外，Detecto认为在港口、矿业和运输领域有强大的增长潜力。

About Detecto

关于Detecto

Detecto was established as an independent business line within the company MTB Distribuciones Tecnologicas SL to provide the best possible service to professionals working in the prevention and treatment of addictive behaviors. Today, Detecto is a leading supplier in this sector in Spain, offering training and information to its clients on new drugs, technologies, and more.

Detecto作为MTB技术分销公司内的一个独立业务线成立，旨在为从事成瘾行为预防和治疗的专业人士提供最佳服务。如今，Detecto已成为西班牙该领域的领先供应商，为其客户提供有关新型毒品、技术等方面的相关培训和信息。

The Spanish labor market and the increasing emphasis on worker safety and well-being, particularly in high-risk sectors, is a key focus for Detecto which has achieved considerable success. Detecto provides consulting services to companies across Spain concerning substance abuse in the workplace, its safety implications, and prevention strategies.

西班牙劳动力市场以及对工人安全和福祉的日益重视，尤其是在高风险行业，是Detecto关注的重点，该公司已取得了显著的成功。Detecto为西班牙各地的公司提供有关职场药物滥用、其安全影响及预防策略的咨询服务。

The company further provides advice to businesses on how to offer their employees an ethical, legal, and effective way to prevent the abuse of psychoactive substances. As part of this service, Detecto supplies cutting-edge technology to detect substance use in a way that is minimally invasive and highly effective..

该公司还为企业提供咨询服务，指导它们如何为员工提供一种合乎道德、合法且有效的预防滥用精神活性物质的方法。作为这项服务的一部分，Detecto 提供尖端技术，以一种最小侵入性和高效的方式检测物质使用情况。

About Intelligent Bio Solutions Inc.

关于智能生物解决方案公司

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields.

智能生物解决方案公司（纳斯达克股票代码：INBS）是一家提供智能、快速、无创检测解决方案的医疗技术公司。该公司认为，其智能指纹药物筛查系统将通过指纹汗液分析彻底改变便携式检测，并且该技术有潜力在更多领域得到广泛应用。

Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries.

设计为一种卫生且经济高效的系统，该测试筛查职场常见药物的近期使用情况，包括鸦片类、可卡因、甲基苯丙胺和大麻。凭借数秒内的样本采集和十分钟内出结果，这项技术将成为安全关键行业中雇主们的宝贵工具。

The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners..

公司在美国以外的当前客户群体包括建筑、制造和工程、运输和物流公司、戒毒组织以及验尸官办公室。

For more information, visit: http://www.ibs.inc

有关更多信息，请访问：http://www.ibs.inc

Forward-Looking Statements:

前瞻性声明：

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.'s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others.

本新闻稿中的某些陈述属于1933年《证券法》第27A条、1934年《证券交易法》第21E条以及1995年《私人证券诉讼改革法案》所定义的前瞻性陈述，这些陈述涉及风险和不确定性。本新闻稿中的前瞻性陈述包括但不限于Intelligent Bio Solutions Inc.成功开发和商业化其药物和诊断测试的能力、从合作伙伴关系和协作中实现商业利益以及获得监管批准等。

Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc.

尽管Intelligent Bio Solutions Inc.认为这些前瞻性陈述中反映的预期在作出时是合理的，但预期可能证明与这些前瞻性陈述中表达或暗示的结果有重大不同。Intelligent Bio Solutions Inc.

has attempted to identify forward-looking statements by terminology, including 'believes,' 'estimates,' 'anticipates,' 'expects,' 'plans,' 'projects,' 'intends,' 'potential,' 'may,' 'could,' 'might,' 'will,' 'should,' 'approximately' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements.

已尝试通过术语识别前瞻性陈述，包括“相信”、“估计”、“预期”、“计划”、“项目”、“意图”、“潜力”、“可能”、“能够”、“或许”、“将”、“应该”、“大约”或其他传达未来事件或结果不确定性的词语来识别这些前瞻性陈述。

These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions' public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events..

这些声明仅为预测，涉及已知和未知的风险、不确定性以及其他因素，包含在 Intelligent Bio Solutions 向证券交易委员会提交的公开文件中。本发布中包含的任何前瞻性声明仅在其发布日期有效。Intelligent Bio Solutions 没有义务更新本发布中包含的任何前瞻性声明，以反映其日期之后发生的事件或情况，或反映未预见事件的发生。

Company Contact:

公司联系人：

Intelligent Bio Solutions Inc.

智能生物解决方案公司

info@ibs.inc

LinkedIn | Twitter

LinkedIn | Twitter

Investor & Media Contact:

投资者和媒体联系：

Valter Pinto, Managing Director

瓦尔特·平托，董事总经理

KCSA Strategic Communications